Collectively, the authors posit that alterations in eIF2α play a pivotal role in their disease model, as evidenced by the alleviation of PD-like symptoms through the reduction of ER stress and neuronal death following salubrinal treatment [144]. This evidence concerns the gene EIF2A and Parkinson disease.